Why is Gland Pharma falling/rising?

As of 05-Aug, Gland Pharma Ltd's stock price is currently at 1,964.45, reflecting a decrease of 16.6 points or 0.84%. The stock has shown a decline of 6.18% over the past week, while it has increased by 5.05% over the past month. Despite this recent monthly gain, the stock is down 7.11% over the past year and has underperformed significantly over the last three years with a decline of 13.11%. Today's trading saw the stock touch an intraday low of Rs 1,933.85, indicating a drop of 2.38%. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 71.87% compared to the five-day average. However, the company maintains a low debt-to-equity ratio and has reported strong financial results in June, which could provide some support for the stock.
In the broader market context, Gland Pharma's recent performance has been relatively weak compared to the Sensex, which has only declined by 0.77% over the past week. The stock's performance today is in line with its sector, but the significant drop in delivery volume may indicate waning investor interest. Despite high institutional holdings at 40.24%, which typically suggest a level of confidence in the company's fundamentals, the overall market sentiment appears to be affecting the stock negatively. The stock's moving averages indicate mixed signals, being higher than the 50, 100, and 200-day averages but lower than the 5 and 20-day averages, further complicating its short-term outlook.